Your browser doesn't support javascript.
loading
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
Short, Nicholas J; Benton, Christopher B; Chen, Hsiang-Chun; Qiu, Peng; Gu, Lisa; Pierce, Sherry; Brandt, Mark; Maiti, Abhishek; Min, Taejin L; Naqvi, Kiran; Quintas-Cardama, Alfonso; Konopleva, Marina; Kadia, Tapan; Cortes, Jorge; Garcia-Manero, Guillermo; Ravandi, Farhad; Jabbour, Elias; Kantarjian, Hagop; Andreeff, Michael.
Afiliação
  • Short NJ; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Benton CB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen HC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Qiu P; Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia.
  • Gu L; Baylor College of Medicine, Houston, Texas.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Brandt M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Maiti A; Department of Internal Medicine, The University of Texas Health Science Center, Houston, Texas.
  • Min TL; Baylor College of Medicine, Houston, Texas.
  • Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Quintas-Cardama A; Novartis, Basel, Switzerland.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortes J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 91(12): 1221-1226, 2016 12.
Article em En | MEDLINE | ID: mdl-27474808
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Crise Blástica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Crise Blástica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article